MARY EDWARDS: Open Payments
NPI 1154624492 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 38 payments from 19 companies in 2025. Trend: 2023 $530 · 2024 $728 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $238 |
| Axsome Therapeutics, Inc. | 7 | $163 |
| Lundbeck LLC | 4 | $67 |
| Cipher Pharmaceuticals US LLC | 1 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
Products named: FANAPT, Auvelity, REXULTI, Natroba, AUSTEDO XR, ABILIFY ASIMTUFII, NUZYRA, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
